These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30857342)

  • 1. Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies.
    Sonbol MB; Ahn DH; Bekaii-Saab T
    Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30857342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells in gastrointestinal cancers: The road less travelled.
    Mikhail S; Zeidan A
    World J Stem Cells; 2014 Nov; 6(5):606-13. PubMed ID: 25426257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.
    Huang TX; Guan XY; Fu L
    Am J Cancer Res; 2019; 9(9):1889-1904. PubMed ID: 31598393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.
    Pádua D; Figueira P; Ribeiro I; Almeida R; Mesquita P
    Front Cell Dev Biol; 2020; 8():442. PubMed ID: 32626705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.
    Koury J; Zhong L; Hao J
    Stem Cells Int; 2017; 2017():2925869. PubMed ID: 28356914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
    Mudra SE; Sadhukhan P; Ugurlu MT; Alam S; Hoque MO
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, Culture and Targeting of Cancer Stem Cells.
    Herreros-Pomares A
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
    Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
    J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.